Building Bridges to Innovation 2015

Whitepaper | McKinsey & Co.

Building Bridges to Innovation 2015

Commissioned for the BioCentury China Healthcare Summit, this report discusses recent trends impacting the short- and long-term potential of the China pharmaceuticals market. The report explores root causes of the market slow-down observed in 2015, and assesses China's latest policy developments meant to better support innovation. In the report, McKinsey also launches the China Drug Innovation Index (CDII), the first holistic assessment of China’s innovation ecosystem to be tracked annually.